2024-04-05 06:34:44 ET
Summary
- I like Accolade's choice of new partners added year-to-date, as I think the services provided by these partners will be well received by its clients' employees.
- ACCD's latest "Artificial Intelligence Excellence Award" presented by the business Intelligence Group provides a validation of the potential AI-related tailwinds for the company.
- A review of Accolade's most recent developments leaves me bullish on the stock.
Elevator Pitch
Accolade, Inc. ( ACCD ) shares are rated as a Buy. Business data provider GlobalData refers to ACCD as a "personalized healthcare advocacy company" that "reduces healthcare costs for employers and improves health and benefits for employees."...
Read the full article on Seeking Alpha
For further details see:
Accolade: Staying Bullish On Favorable Developments